News
Humana invests $100 million in telehealth start-up Heal
Health insurance provider Humana is partnering with telehealth start-up Heal, which includes a $100 million investment that will be used to help the five-year-old company...
News
BioTelemetry acquires remote patient monitoring platform from Centene subsidiary
BioTelemetry, the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced...
News
GLC + GLCM Announce Rapid Detection COVID-19 Test – Results in Seconds
Graphene Leaders Canada (GLC) Inc. together with subsidiary GLC Medical (GLCM) Inc. announce their development of a graphene-enhanced sensor for use in their COVID-19 Rapid...
News
Qualigen Therapeutics Begins Shipping FastPack COVID-19 Antibody Test
Qualigen Therapeutics, Inc. announced it has begun commercial shipments of its FastPack® SARS-CoV-2 IgG diagnostic test for COVID-19 antibodies. This test has been submitted to...
News
Luciole Medical AG and Adolphe de Rothschild Research Collaboration in Brain Oxygenation Monitoring
Luciole Medical AG, a Swiss medical technology company, and Hôpital Fondation Adolphe de Rothschild announce a collaboration in brain metabolism monitoring research. The two organizations...
News
Drug diversion and compliance experts join ANiGENT’s Board of Advisors
Three drug diversion prevention influencers — Pamela Mergens, M.D.; Simone Cummings, M.H.A., Ph.D.; and global life sciences executive Neal Long — have recently joined ANiGENT’s...
News
Recordati: Results From the Phase III LINC-3 Study Of ISTURISA for the Treatment of Cushing’s Disease Published in Lancet Diabetes & Endocrinology
Recordati Rare Diseases Inc. announces that Lancet Diabetes & Endocrinology has published results from the Phase III LINC-3 pivotal study of ISTURISA, recently approved for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.